One in four older US veterans report being diagnosed with cardiovascular disease in their lifetime, according to study findings.

Coffee drinking timing is associated with all-cause and cardiovascular disease-specific mortality risk, according to study findings.

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Doxycycline postexposure prophylaxis initiation is associated with decreases in sexually transmitted infections.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

The risk for STI reinfection and condom use at last sexual encounter vary by age and sexual orientation among people in the UK aged 16 to 24.

Telemedicine is not reliable for assessing Centor criteria for patients with an acute sore throat, according to study findings.

The first-ever US FDA guidelines on lead in baby food are under fire from health experts who argue the limits are too lenient and fail to protect children from harmful exposure to toxic metals.

For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.

A Louisiana resident has died after being hospitalized with bird flu in December of last year, marking the first known US death from the virus.